Nissay Asset Management Corp Abbott Laboratories Transaction History

Nissay Asset Management Corp

$15.5 Billion
Q3 2024

A detailed history of Nissay Asset Management Corp transactions in Abbott Laboratories stock. As of the latest transaction made, Nissay Asset Management Corp holds 215,947 shares of ABT stock, worth $24.7 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

215,947

Previous 212,373 1.68%

Holding current value

$24.7 Million

Previous $22.1 Million 11.57%

% of portfolio

0.16%

Previous 0.15%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$100.07 - $118.13 $357,650 - $422,196	3,574 Added 1.68%	215,947 $24.6 Million
Q2 2024 Aug 14, 2024	BUY	$100.73 - $112.44 $513,622 - $573,331	5,099 Added 2.46%	212,373 $22.1 Million
Q1 2024 May 15, 2024	SELL	$109.52 - $120.96 $177,860 - $196,439	-1,624 Reduced 0.78%	207,274 $23.6 Million
Q4 2023 Feb 14, 2024	BUY	$90.19 - $110.4 $608,241 - $744,537	6,744 Added 3.34%	208,898 $23 Million
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $569,836 - $683,708	5,965 Added 3.04%	202,154 $19.6 Million
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $378,126 - $421,312	-3,752 Reduced 1.88%	196,189 $21.4 Million
Q1 2023 May 15, 2023	SELL	$96.86 - $114.01 $803,066 - $945,256	-8,291 Reduced 3.98%	199,941 $20.2 Million
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $130,327 - $152,893	1,371 Added 0.66%	208,232 $22.9 Million
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $1.21 Million - $1.4 Million	-12,500 Reduced 5.7%	206,861 $20 Million
Q2 2022 Aug 15, 2022	BUY	$102.07 - $123.37 $2.14 Million - $2.58 Million	20,922 Added 10.54%	219,361 $23.8 Million
Q1 2022 May 16, 2022	BUY	$114.02 - $139.04 $366,802 - $447,291	3,217 Added 1.65%	198,439 $23.5 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $570,833 - $698,953	4,941 Added 2.6%	195,222 $27.5 Million
Q3 2021 Nov 10, 2021	BUY	$116.66 - $129.06 $1.84 Million - $2.04 Million	15,806 Added 9.06%	190,281 $22.5 Million
Q2 2021 Aug 13, 2021	BUY	$105.79 - $124.53 $146,201 - $172,100	1,382 Added 0.8%	174,475 $20.2 Million
Q1 2021 May 11, 2021	SELL	$108.84 - $128.23 $459,087 - $540,874	-4,218 Reduced 2.38%	173,093 $20.7 Million
Q4 2020 Feb 08, 2021	BUY	$105.0 - $114.42 $45,360 - $49,429	432 Added 0.24%	177,311 $19.4 Million
Q3 2020 Oct 20, 2020	SELL	$91.64 - $111.29 $2.2 Million - $2.67 Million	-24,011 Reduced 11.95%	176,879 $19.3 Million
Q2 2020 Jul 27, 2020	BUY	$76.57 - $98.0 $374,580 - $479,416	4,892 Added 2.5%	200,890 $18.4 Million
Q1 2020 May 05, 2020	BUY	$62.82 - $91.86 $432,641 - $632,639	6,887 Added 3.64%	195,998 $15.5 Million
Q4 2019 Feb 14, 2020	SELL	$78.51 - $87.4 $382,265 - $425,550	-4,869 Reduced 2.51%	189,111 $16.4 Million
Q3 2019 Nov 14, 2019	BUY	$81.84 - $88.74 $499,224 - $541,314	6,100 Added 3.25%	193,980 $16.2 Million
Q2 2019 Aug 07, 2019	SELL	$72.88 - $85.0 $520,654 - $607,240	-7,144 Reduced 3.66%	187,880 $15.8 Million
Q1 2019 May 03, 2019	SELL	$66.22 - $80.06 $394,936 - $477,477	-5,964 Reduced 2.97%	195,024 $15.6 Million
Q4 2018 Feb 06, 2019	SELL	$65.56 - $74.27 $21,438 - $24,286	-327 Reduced 0.16%	200,988 $14.5 Million
Q3 2018 Oct 30, 2018	BUY	$60.81 - $73.36 $310,435 - $374,502	5,105 Added 2.6%	201,315 $14.8 Million
Q2 2018 Aug 08, 2018	BUY	$57.57 - $63.54 $198,616 - $219,213	3,450 Added 1.79%	196,210 $12 Million
Q1 2018 May 14, 2018	SELL	$56.27 - $63.62 $154,123 - $174,255	-2,739 Reduced 1.4%	192,760 $11.6 Million
Q4 2017 Feb 14, 2018	BUY	$53.68 - $57.47 $10.5 Million - $11.2 Million	195,499	195,499 $11.2 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nissay Asset Management Corp , based on Form 13F filings with the SEC.

News

Stay updated on Nissay Asset Management Corp with notifications on news.

Account

Nissay Asset Management Corp Abbott Laboratories Transaction History